ROSENWALD LINDSAY A MD 4
4 · Fortress Biotech, Inc. · Filed Jul 10, 2024
Insider Transaction Report
Form 4
ROSENWALD LINDSAY A MD
Director
Transactions
- Purchase
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-08$7.35/sh+5,000$36,765→ 117,500 total
Footnotes (1)
- [F1]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 8, 2024 was $7.29 to $7.47. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.